Plasminogen binds the heparin-binding domain of insulin-like growth factor-binding protein-3

American Journal of Physiology - Endocrinology and Metabolism

Volumn 275, Issue 2 38-2, 1998, Pages

  Campbell, Phil G ^a   Durham, Susan K ^b   Suwanichkul, Adisak ^b   Hayes, James D ^a   Powell, David R ^b,c  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Insulin like growth factors; Kringle domains; Plasmin; Proteolysis; Tissue plasminogen activator

Indexed keywords

HEPARIN; PLASMIN; PLASMINOGEN; PROTEINASE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BIOAVAILABILITY; CHO CELL; CONTROLLED STUDY; DISSOCIATION CONSTANT; IMMUNOBLOTTING; IMMUNORADIOMETRIC ASSAY; KRINGLE DOMAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; RADIOIMMUNOASSAY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 0031820995     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1998.275.2.e321     Document Type: Article

References (40)

1. Andress, D. L., S. M. Loop, J. Zapf, and M. C. Kiefer. Carboxy-truncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells. Biochem. Biophys. Res. Commun. 195: 25-30, 1993.
2. Angelloz-Nicoud, P., and M. Binoux. Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3). Endocrinology 136: 5485-5492, 1995.
3. Baxter, R. C., and S. M. Firth. Modulation of human IGF binding protein-3 activity by structural modification. Prog. Growth Factor Res. 6: 215-222, 1995.
4. Blat, C., J. Villaudy, and M. Binoux. In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. J. Clin. Invest. 93: 2286-2290, 1994.
5. Booth, B. A., M. Boes, D. L. Andress, B. L. Dake, M. C. Kiefer, C. Maack, R. J. Linhardt, K. Bar, E. E. O. Caldwell, J. Weiler, and R. S. Bar. IGFBP-3 and IGFBP-5 association with endothelial cells: role of C-terminal heparin binding domain. Growth Regul. 5: 1-7, 1995.
6. Burch, W. M., J. Correa, J. E. Shively, and D. R. Powell. The 25 kiloDalton insulin-like growth factor (IGF) binding protein inhibits both basal and IGF-I-mediated growth of chick embryo pelvic cartilage in vitro. J. Clin. Endocrinol. Metab. 70: 173-180, 1990.
7. Campbell, P. G., and D. L. Andress. Plasma degradation of insulin-like growth factor-binding protein-5 (IGFBP-5): regulation by IGFBP-5-(201-218). Am. J. Physiol. 273 (Endocrinol. Metab. 36): E996-E1004, 1997.
8. Campbell, P. G., J. F. Novak, T. B. Yanosick, and J. H. McMaster. Involvement of the plasmin system in dissociation of the insulin-like growth factor-binding protein complex. Endocrinology 130: 1401-1412, 1992.
9. Campbell, P. G., K. Wines, T. B. Yanosick, and J. F. Novak. Binding and activation of plasminogen on the surface of osteosarcoma cells. J. Cell. Physiol. 159: 1-10, 1994.
10. Castellino, F. J., and J. R. Powell. Human plasminogen. Methods Enzymol. 80: 365-378, 1981.
11. Clemmensen, I., L. C. Petersen, and C. Kluft. Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin. Eur. J. Biochem. 156: 327-333, 1986.
12. Conover, C. A., and D. D. DeLeon. Acid-activated insulin-like growth factor binding protein-3 proteolysis in normal and transformed cells. J. Biol. Chem. 269: 7076-7080, 1994.
13. Conover, C. A., M. Ronk, F. Lombana, and D. R. Powell. Structural and biological characterization of bovine insulin-like growth factor binding protein-3. Endocrinology 127: 2795-2803, 1990.
14. Cubbage, M. L., A. Suwanichkul, and D. R. Powell. Insulin-like growth factor binding protein-3 (IGFBP-3): organization of the human chromosomal gene and demonstration of promoter activity. J. Biol. Chem. 265: 12642-12649, 1990.
15. DePoli, P., T. Bacon-Baguley, S. Dendra-Franczak, M. T. Cederholm, and D. A. Walz. Thrombospondin interaction with plasminogen. Evidence for binding to a specific region of the kringle structure of plasminogen. Blood 73: 976-982, 1989.
16. Durham, S. K., S. Mohan, F. Liu, B. K. Baker, P. D. K. Lee, R. L. Hintz, C. A. Conover, and D. R. Powell. Bioactivity of a 29 kD IGFBP-3 fragment present in excess in chronic renal failure serum. Pediatr. Res. 42: 335-341, 1997.
17. Fielder, P. J., R. G. Rosenfeld, H. C. B. Graves, K. Grandbois, C. A. Maack, S. Sawamura, Y. Ogawa, A. Sommer, and P. Cohen. Biochemical analysis of prostate-specific antigen-proteolysed insulin-like growth factor binding protein. Growth Regul. 1: 164-172, 1994.
18. Fowlkes, J. L., J. J. Enghild, K. Suzuki, and H. Nagase. Matrix metalloproteases degrade insulin-like growth factor binding protein-3 in dermal fibroblast cultures. J. Biol. Chem. 269: 25742-25746, 1994.
19. Frost, V. J., V. M. Macaulay, J. A. H. Wass, and J. M. P. Holly. Proteolytic modification of insulin-like growth factor-binding proteins: comparison of conditioned media from human cell lines, circulating proteases and characterized enzymes. J. Endocrinol. 138: 545-554, 1993.
20. Heding, A., R. Gill, Y. Ogawa, P. DeMeyts, and R. M. Shymko. Biosensor measurement of the binding of insulin-like growth factors 1 and 2 and their analogues to the insulin-like growth factor binding protein-3. J. Biol. Chem. 271: 13948-13952, 1996.
21. Kelm, R. J., Jr., N. A. Swords, T. Orfeo, and K. G. Mann. Osteonectin in matrix remodeling. A plasminogen-osteonectin-collagen complex. J. Biol. Chem. 269: 30147-30153, 1994.
22. Lalou, C., C. Silve, R. Rosato, B. Segovia, and M. Binoux. Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF-binding protein-3 production and proteolysis in human osteosarcoma cells. Endocrinology 135: 2318-2326, 1994.
23. Lee, C. Y., and M. M. Rechler. Proteolysis of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in 150-kilodalton IGFBP complexes by a cation-dependent protease activity in adult rat serum promotes the release of bound IGF-I. Endocrinology 137: 2051-2058, 1996.
24. Leong, S. R., R. C. Baxter, T. Camerato, J. Dai, and W. I. Wood. Structure and functional expression of the acid-labile subunit of the insulin-like growth factor binding protein complex. Mol. Endocrinol. 6: 870-876, 1992.
25. Lijnen, H. R., M. Hoylaerts, and D. Collen. Isolation and characterization of a human plasma protein with high affinity for the lysine binding sites in plasminogen. J. Biol. Chem. 255: 10214-10222, 1980.
26. Liu, F., R. L. Hintz, A. Khare, R. P. DiAugustine, D. R. Powell, and P. D. K. Lee. Immunoblot studies of the IGF-related acid-labile subunit. J. Clin. Endocrinol. Metab. 79: 1883-1886, 1994.
27. Martin, J. L., and R. C. Baxter. Insulin-like growth factor binding proteins from human plasma. J. Biol. Chem. 261: 8754-8760, 1986.
28. Plow, E. F., J. Felez, and L. A. Miles. Cellular regulation of fibrinolysis. Thromb. Haemost. 66: 32-36, 1991.
29. Preissner, K. T. Specific binding of plasminogen to vitronectin: evidence for a modulatory role of vitronectin on fibrin(ogen)-induced plasmin formation by tissue plasminogen activator. Biochem. Biophys. Res. Commun. 168: 966-971, 1990.
30. Rechler, M. M. Insulin-like growth factor binding proteins. Vitam. Horm. 47: 1-114, 1993.
31. Salonen, E.-M., O. Saksela, T. Vartio, A. Vaheri, L. S. Nielsen, and J. Seuthen. Plasminogen and tissue-type plasminogen activator bind to immobilized fibronectin. J. Biol. Chem. 260: 12302-12307, 1985.
32. Salonen, E.-M., A. Zitting, and A. Vaheri. Laminin interacts with plasminogen and its tissue-type activator. FEBS Lett. 172: 29-32, 1984.
33. Skottner, A., V. Arrhenius-Nyberg, M. Kanje, and L. Fryklund. Anabolic and tissue-repair functions of recombinant insulin-like growth factor-I. Acta Paediatr. Scand. 367, Suppl.: 63-66, 1990.
34. Spratt, S. K., G. P. Tatsuno, M. K. Yamanaka, B. C. Ark, J. Detmer, D. Mascarenhas, J. Flynn, C. Talkington-Verser, and E. M. Spencer. Cloning and expression of human insulin-like growth factor binding protein 3. Growth Factors 3: 63-72, 1990.
35. Stack, M. S., T. L. Moser, and S. V. Pizzo. Binding of human plasminogen to basement membrane (type IV) collagen. Biochem. J. 284: 103-108, 1992.
36. Suwanichkul, A., S. V. Allander, S. L. Morris, and D. R. Powell. Glucocorticoids and insulin regulate expression of the human gene for insulin-like growth factor binding protein-1 through proximal promoter elements. J. Biol. Chem. 269: 30835-30841, 1994.
37. Tan, A. K., and D. L. Eaton. Activation and characterization of procarboxypeptidase B from human plasma. Biochemistry 34: 5811-5816, 1995.
38. Varadj, A., and L. Patthy. Kringle 5 of human plasminogen carries a benzamidine-binding site. Biochem. Biophys. Res. Commun. 103: 97-102, 1981.
39. Wiman, B., H. R. Lijnen, and D. Collen. On the specific interaction between the lysine-binding sites in plasmin and complementary sites in α2-antiplasmin and in fibrinogen. Biochim. Biophys. Acta 579: 142-154, 1979.
40. Wood, W. I., G. Cachianes, W. J. Henzel, G. A. Winslow, S. A. Spencer, R. Hellmiss, J. L. Martin, and R. C. Baxter. Cloning and expression of the growth-hormone-dependent insulin-like growth factor-binding protein. Mol. Endocrinol. 2: 1178-1185, 1988.